Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	249,955 L.L
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	435,405 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L
D07AC13	XEMADERM	G	Mometasone furoate - 0.1%	0.1%	Cream	335,961 L.L
D07AC13	KONEX	G	Mometasone furoate - 0.1%	0.1%	Solution	385,683 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Lotion	239,332 L.L
D07XC03	ELICA M	G	Mometasone furoate - 0.1%, Miconazole nitrate - 2%		Cream	459,594 L.L
D07AC13	ELICA	G	Mometasone furoate - 1mg/g	0.1%	Cream	341,336 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
D07XC03	ELICASAL	G	Mometasone furoate - 1mg/g, Salicylic acid - 50mg/g		Ointment	462,282 L.L
R01AD09	METASONE	G	Mometasone furoate - 50mcg/actuation	50mcg/actuation	Spray	419,791 L.L
R01AX	METASONE-D	G	Mometasone furoate - 50mcg/actuation, Oxymetazoline HCl - 25mcg/actuation		Spray	534,977 L.L
D07AC13	ELICA	G	Mometasone furoate micronized - 1mg/g	0.1%	Ointment	399,121 L.L
R03DC03	SINGULAIR	B	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	1,248,430 L.L
R03DC03	AIRFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	LUKAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	978,317 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	1,136,296 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	844,701 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	228,453 L.L
R03DC03	UNICAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	SINGULAIR PEDIATRIC	B	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,217,521 L.L
R03DC03	LUKAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	851,996 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,184,140 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,034,119 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, mouth dissolving	405,840 L.L
R03DC03	UNICAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
R03DC03	SINGULAIR (PEDIATRIC)	B	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	1,217,521 L.L

Mometasone furoate - 0.1%

0.1%

Cream